SEC Form 4 · accession 0001209191-17-012145
Pediatrix Medical Group, Inc. · MD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Vivian Lopez-Blanco
Officer — Chief Financial Officer
Period of report
Feb 17, 2017
Accepted (ET)
Feb 17, 2017 · 4:36 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000893949
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Feb 17, 2017 | S | 15,164 | $70.0083 | D | 59,097 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price reported in Column 4 is an weighted average price. These shares were sold in seven separate transactions with prices ranging from $70.00 to $70.03 for an average weighted sales price of $70.0083. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.